Impact of polyols on Oral microbiome of Estonian schoolchildren
Makinen PL; Mandar R; Saag M; Olak J; Stsepetova J; Vahlberg T; Honkala S; Preem JK; Krjutskov K; Makinen K; Nommela R; Bosscher D; Oopkaup K; Nolvak H; Runnel R; Honkala E; Vermeiren J; de Cock P; Truu J
Impact of polyols on Oral microbiome of Estonian schoolchildren
Makinen PL
Mandar R
Saag M
Olak J
Stsepetova J
Vahlberg T
Honkala S
Preem JK
Krjutskov K
Makinen K
Nommela R
Bosscher D
Oopkaup K
Nolvak H
Runnel R
Honkala E
Vermeiren J
de Cock P
Truu J
BMC
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021042825109
https://urn.fi/URN:NBN:fi-fe2021042825109
Tiivistelmä
BackgroundOral microbiome has significant impact on both oral and general health. Polyols have been promoted as sugar substitutes in prevention of oral diseases. We aimed to reveal the effect of candies containing erythritol, xylitol or control (sorbitol) on salivary microbiome.MethodsNinety children (11.30.6years) consumed candies during 3years. Microbial communities were profiled using Illumina HiSeq 2000 sequencing and real-time PCR.ResultsThe dominant phyla in saliva were Firmicutes (39.1%), Proteobacteria (26.1%), Bacteroidetes (14.7%), Actinobacteria (12%) and Fusobacteria (6%). The microbiome of erythritol group significantly differed from that of the other groups. Both erythritol and xylitol reduced the number of observed bacterial phylotypes in comparison to the control group. The relative abundance of the genera Veillonella, Streptococcus and Fusobacterium were higher while that of Bergeyella lower after erythritol intervention when comparing with control. The lowest prevalence of caries-related mutans streptococci corresponded with the lowest clinical caries markers in the erythritol group.ConclusionsDaily consumption of erythritol, xylitol or control candies has a specific influence on the salivary microbiome composition in schoolchildren. Erythritol is associated with the lowest prevalence of caries-related mutans streptococci and the lowest levels of clinical caries experience.Trial registration p id=Par5 ClinicalTrials.gov Identifier NCT01062633.
Kokoelmat
- Rinnakkaistallenteet [19207]